Recombinant MVA HIV vaccine

Modified Vaccinia Ankara-based HIV vaccine · Bavarian Nordic

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant MVA HIV vaccine, covering 2009-07-10 to 2009-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Single-Blind, Controlled Safety and Immunogenicity Study of Recombinant MVA Virus to Treat HIV Infection [Phase 1, Phase 2]

See pricing